tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMNN Stock Latest News

Imunon announces database kock for Phase 2 studyof IMNN-001 in OC
The FlyImunon announces database kock for Phase 2 studyof IMNN-001 in OC
1M ago
IMNN
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer
PremiumPress Releases
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer
1M ago
IMNN
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
PremiumPress Releases
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
2M ago
IMNN
Imunon announces first participants treated in IMNN-101 Phase 1 trial
PremiumThe Fly
Imunon announces first participants treated in IMNN-101 Phase 1 trial
2M ago
IMNN
Imunon files $75M mixed securities shelf
PremiumThe Fly
Imunon files $75M mixed securities shelf
2M ago
IMNN
Imunon announces abstract on Phase 2 study with IMNN-001 at ASCO meeting
PremiumThe FlyImunon announces abstract on Phase 2 study with IMNN-001 at ASCO meeting
2M ago
IMNN
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
PremiumPress Releases
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
2M ago
IMNN
IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
PremiumPress Releases
IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
3M ago
IMNN
Imunon announces site activation for IMNN-101 Phase 1 vaccine study
PremiumThe Fly
Imunon announces site activation for IMNN-101 Phase 1 vaccine study
3M ago
IMNN
Imunon sees cash runway to end of 2024
PremiumThe Fly
Imunon sees cash runway to end of 2024
3M ago
IMNN
Imunon appoints Stacy Lindborg as president, CEO
PremiumThe Fly
Imunon appoints Stacy Lindborg as president, CEO
3M ago
BCLI
IMNN
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
3M ago
IMNN
Imunon reports Q1 EPS (52c), consensus (57c)
PremiumThe FlyImunon reports Q1 EPS (52c), consensus (57c)
3M ago
IMNN
Is IMNN a Buy, Before Earnings?
PremiumPre-Earnings
Is IMNN a Buy, Before Earnings?
3M ago
IMNN
Imunon Appoints Stacy R. Lindborg as New President and CEO
PremiumCompany Announcements
Imunon Appoints Stacy R. Lindborg as New President and CEO
3M ago
8K
IMNN
Imunon appoints Lindborg as President, CEO
PremiumThe Fly
Imunon appoints Lindborg as President, CEO
3M ago
BCLI
IMNN
IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
PremiumPress Releases
IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
3M ago
IMNN
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
PremiumPress Releases
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
3M ago
IMNN
Imunon’s IND application cleared to begin human testing of IMNN-101
PremiumThe Fly
Imunon’s IND application cleared to begin human testing of IMNN-101
3M ago
IMNN
Imunon reports compliance with Nasdaq listing requirements
PremiumThe FlyImunon reports compliance with Nasdaq listing requirements
4M ago
IMNN
IMUNON Reports Compliance with Nasdaq Listing Requirements
PremiumPress Releases
IMUNON Reports Compliance with Nasdaq Listing Requirements
4M ago
IMNN
Imunon price target raised to $13 from $12 at H.C. Wainwright
PremiumThe Fly
Imunon price target raised to $13 from $12 at H.C. Wainwright
4M ago
IMNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >